Horizon Surgical Systems, Inc., a privately-owned company specializing in micro-robotics for microsurgery, has successfully closed a $30 million Series A funding round.

The financing was led by ExSight Ventures and a major corporate investor, with additional support from Main Street Advisors and UC Investments. The funds will be used to advance the development of Horizon’s technology platform, leading up to its first human trials and expanding the company’s team.

Horizon’s Polaris system aims to revolutionise eye surgery by utilising cutting-edge robotics, advanced imaging technology, and artificial intelligence to enhance surgeons’ capabilities.

The company’s robotic platform is designed to improve surgical outcomes while increasing access to eye care. The system is expected to make procedures more efficient and safer by enabling more precise and consistent surgical interventions.

As part of this financing round, Horizon has strengthened its board of directors with the addition of Dr. Firas M. Rahhal, Founder and General Partner of ExSight Ventures, and Dr. William A.

Link, a specialist in early-stage biopharma and medical device investments. Dr. Link has a long history in the medical optics industry, including founding Chiron Vision and American Medical Optics, both of which were eventually acquired by larger corporations.

Horizon’s founder and CEO, Dr. Jean-Pierre Hubschman, highlighted the company’s commitment to advancing surgical robotics.

The Polaris platform, incorporating AI and precision robotic control, is expected to improve surgical accuracy and efficiency, helping to deliver better patient outcomes. The company is now focused on progressing toward its first human trials with the backing of its investors and leadership team.




Source: businesswire.com

Report Abuse